MYO5B and colorectal cancer: Low protein levels of MYO5B has been shown to be associated with motility of gastric cells [30], and expression level and mutations in MYO5B has been reported as a powerful prognostic biomarker in colorectal cancer, which might help to stratifying patients for adjuvant therapy [30,32].